The REVOLUTION project: planning and performing surgical revascularization based solely on coronary computed tomography angiography [0.03%]
基于冠状动脉CT造影单独进行外科重建手术的REVOLUTION项目：策划与实践
Leonardo Bolognese,Matteo Rocco Reccia,Marco Chioccioli
Leonardo Bolognese
Coronary computed tomography angiography (CCTA) is a non-invasive diagnostic tool that is increasingly being used as an alternative to invasive coronary angiography (ICA) in patients with suspected coronary artery disease (CAD), providing i...
Claudio Borghi,Alessio Bragagni
Claudio Borghi
Systemic arterial hypertension is one of the leading causes of mortality and morbidity worldwide. Despite therapeutic advancements, a significant proportion of hypertensive patients fail to achieve adequate blood pressure control. Renal den...
Enrico Ammirati,Matteo Palazzini,Piero Gentile et al.
Enrico Ammirati et al.
Acute myocarditis (AM) is an inflammatory condition of the myocardium that may lead to severe complications, including acute heart failure and life-threatening ventricular arrhythmias (VAs). In-hospital VAs are estimated to affect 2.5% of a...
Francesco Bianchini,Cristina Aurigemma,Carlo Trani et al.
Francesco Bianchini et al.
Mitral regurgitation (MR) is the most common valvular disease in industrialized countries, with a significant impact on patient quality of life and survival, especially in an increasingly elderly and comorbid population. Repair surgery is c...
Seeking and treating inflammation in ischaemic heart disease: are we ready? [0.03%]
缺血性心脏病中的炎症的检测与治疗：准备好了吗？
Francesco Prati,Flavio Mastroianni,Giulia Paoletti et al.
Francesco Prati et al.
Systemic inflammation, which contributes to atherosclerosis development and progression, plays a significant role in addressing the residual cardiovascular risk. Several studies have highlighted a linear correlation between high levels of t...
Reducing the risk of heart attack: the key role of lipid profiling and atherosclerosis imaging [0.03%]
降血脂与动脉粥样硬化心脏病的影像学检查可降低患心脏病风险
Flavio Giuseppe Biccirè,Flavio Mastroianni,Mihail Celeski et al.
Flavio Giuseppe Biccirè et al.
Despite major improvements in primary and secondary prevention, a flattening in the improvement of survival curves of patients with or at risk of acute myocardial infarction has been reached in recent years. Pharmacological therapies that r...
Filippo Stazi
Filippo Stazi
In the last 10 years, leadless pacemaker (PM) therapy has moved beyond the experimental phase and has become an established therapeutic option. A substantial body of data are now available, even with medium-length follow-ups, suggesting tha...
Should MitraClip also be used in less severe functional mitral regurgitation? The RESHAPE-HF2 study [0.03%]
美塔克兰片是否也可用于较轻度的功能性二尖瓣反流？RESHAPE-HF2研究
Piera Capranzano,Bianca Pellizzeri,Luca Lombardo
Piera Capranzano
Transcatheter edge-to-edge repair (TEER) is currently indicated in symptomatic patients with severe functional mitral regurgitation (MR) who are not eligible for surgery and who have a high likelihood of responding to treatment. This recomm...
Correction to: Genetics in arrhythmogenic cardiomyopathies: where are we now and where are we heading to? [0.03%]
遗传学在心律失常性心肌病中的应用：我们目前所知以及未来展望（ corrections ）
[This corrects the article DOI: 10.1093/eurheartjsupp/suae114.]. © The Author(s) 2025. Published by Oxford University Press on behalf of the European So...
Mikhael F El-Chami,Clemens Steinwender
Mikhael F El-Chami